Éther monométhylique de tripropylène glycol, min 97 %, pour la synthèse, 2,5 l, emballage plastique.

dimethyl 2-[(chloroacetyl)amino]terephthalate, 95.0%, 1g

6-Nitropyridine-2-carboxylic acid, 95.0%, 100mg

1H,1H-Nonafluoro-1-pentanol>97.0%(GC)5g

4-Bromo-1-(difluoromethoxy)-2-fluorobenzene, 95.0%, 5g

4-Methylisoquinoline-5-carboxylic acid, 98%, 100mg

2,8-Dimethylquinoline, 95.0%, 5g

N-[bis(4-methoxyphenyl)methyl]-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide, 95%, 25mg

4-Amino-1H-pyrazole-3-carbonitrile, 95.0%, 250mg

2-(Morpholin-2-yl)ethanol, 95.0%, 1g

4-Phenoxypiperidine, 95.0%, 25g

TERT-BUTYL 3-(4-BROMO-1H-PYRAZOL-1-YL)AZETIDINE-1-CARBOXYLATE, 95.0%, 5g

2,7-Dichloro-9H-xanthene-9-carboxylic acid, 95.0%, 250mg